Comparison of Religious Cognitive Behavioral Therapy, Cognitive Behavioral Therapy, and Citalopram on Depression and Anxiety among Women with Breast Cancer: A Study Protocol for a Randomized Controlled Trial


Affiliations

  • Mazandaran University of Medical Sciences, Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Sari, Iran, Islamic Republic of
  • Mazandaran University of Medical Sciences, Molecular and Cell Biology Research Center, Faculty of Medicine, Sari, Iran, Islamic Republic of
  • Mazandaran University of Medical Sciences, Department of Internal Medicine, Sari, Iran, Islamic Republic of
  • Behavioral Sciences Research Center, Department of Psychiatry Member of Psychiatry, Sari, Iran, Islamic Republic of
  • Mazandaran University of Medical Science, Department of Islamic Thought, Faculty of Medicine, Sari, Iran, Islamic Republic of
  • Mazandaran University of Medical Sciences, Department of Biostatistics, Health Sciences Research Center, Faculty of Health, Sari, Iran, Islamic Republic of
  • Iran University of Medical Sciences (IUMS), Mental Health Research Center (MHRC), Tehran Psychiatric Institute, Tehran, Iran, Islamic Republic of
  • Allame Tabatabai University, Faculty of Psychology and Educational Sciences, Tehran, Iran, Islamic Republic of
  • Mazandaran University of Medical Sciences, Department of Pediatric Nursing, Faculty of Nursing and Midwifery, Sari, Iran, Islamic Republic of

Abstract

There has been evidence supporting the reduction of depression and anxiety by religious psychotherapy in cancer patients, however, there have been scarce randomized controlled trials. Therefore, there is a need for replication in a well-designed study to investigate the efficacy of these interventions among depressed women with breast cancer. A randomized controlled trial is designed to be conducted on 160 women with breast cancer. Participants will be screened for anxiety and depression diagnosed by clinical interview based on the DSM-IV criteria and the Hospital Anxiety Depression Scale. Golriz and Baraheni's Religious Attitude Questionnaire will be used to assess the religious attitude. Individuals meeting the prerequisites will be randomly allocated to four groups, each containing 40 participants, including three intervention groups (RCBT, CBT, and citalopram) and one control group (usual breast cancer treatment). An instrument by the EORTCQLQ-C30 and BR-23 will be used to measure the quality of life. Blood tests will be taken to assess biomarkers with the (ELISA) method. The results will determine whether RCBT is more effective than other treatments. If so, the outcomes of the study will have implications not only for the management of similar problems in cancer patients but also for the management of other chronic diseases.

Keywords

Anxiety, Biomarker, Breast Cancer, Citalopram, Cognitive Behavioral Therapy, Depression, Quality of Life, Religious Cognitive Behavioral Therapy

Subject Discipline

Oncology

Full Text:

References

Malvezzi M, Arfe A, Bertuccio P, Levi F, la Vecchia C, Negri E. European cancer mortality predictions for the year 2011. Annals of Oncology. 2011; 22(4):947–56.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 19952009: analysis of individual data for 25676887 patients from 279 population-based registries in 67 countries (CONCORD2). Lancet. 2014 Nov 26.

O’Connor M, Christensen S, Jensen AB, Moller S, Zachariae R. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer. 2011 Feb 1; 104(3):419–26.

Galloway SK, Baker M, Giglio P, Chin S, Madan A, Malcolm R, et al. Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Research and Treatment.2012; 2012:851276.

Olin JJ. Cognitive function after systemic therapy for breast cancer. Oncology (Williston Park, NY). 2001; 15(5):613–8.

Meyers CA. How chemotherapy damages the central nervous system. J Biol. 2008; 7(4):11.

Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, et al. Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med. 2014 Jun; 3(3):702–9.

Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. Journal of Experimental andClinical Cancer Research. 2008; 27(1):32.

Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis.J Clin Oncol. 2013; 31(6):787–93.

Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain, Behavior, and Immunity. 2011; 25(2):221–9.

Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biological Psychiatry. 2003; 54(3):283–94.

Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006 Jan; 27(1):24–31.

Osborne L, Gispen F, Meilman S, Gocke A, Tosi D, Payne J. Increased inflammatory markers in late pregnancy depression: the role of progesterone and allopregnanolone. Brain, Behavior, and Immunity. 2015; 49:22-3.

Roque S, Correia-Neves M, Mesquita AR, Palha JA, Sousa N. Interleukin-10: a key cytokine in depression? Cardiovasc Psychiatry Neurol. 2009; 2009:187894.

Gazal M, Jansen K, Souza LD, Oses JP, Magalhães PV, Pinheiro R, et al. Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder. Revista Brasileira de Psiquiatria. 2015; 37(4):296–302.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 1; 67(5):446–57.

Tavakoli-Ardakani M, Mehrpooya M, Mehdizadeh M, Hajifathali A, Abdolahi A. Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing hematopoietic stem cell transplantation. International Journal of Hematology-Oncology and Stem Cell Research. 2015; 9(2):80.

Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, et al. Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2009;2.

Shiroma PR, Thuras P, Johns B, Lim KO. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression. Int J Geriatr Psychiatry. 2014 Apr 4.

Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, et al. Tamoxifen’s protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer. 2008 Aug 19; 99(4):616–21.

Rizzo M, Creed F, Goldberg D, Meader N, Pilling S. A systematic review of non-pharmacological treatments for depression in people with chronic physical health problems. J Psychosom Res. 2011 Jul; 71(1):18–27.

Garlick M, Wall K, Corwin D, Koopman C. Psycho-spiritual integrative therapy for women with primary breast cancer. J Clin Psychol Med Settings. 2011 Mar;18(1):78–90.

Fallah R, Golzari M, Dastani M, Akbari ME. Integrating spirituality into a group psychotherapy

program for women surviving from breast cancer. Iranian Journal of Cancer Prevention. 2011; 4(3):141–3.

Olver IN, Dutney A. A randomized, blinded study of the impact of intercessory prayer on spiritual well-being in patients with cancer. Altern Ther Health Med. 2012 Sep-Oct; 18(5):18–27.

Shaw B, Han JY, Kim E, Gustafson D, Hawkins R, Cleary J, et al. Effects of prayer and religious expression within computer support groups on women with breast cancer. PsychoOncology. 2007; 16(7):676–87.

Koenig HG. Religious versus conventional psychotherapy for major depression in patients with chronic medical illness: rationale, methods, and preliminary results. Depress Res Treat. 2012; 2012:460419.

Andrews JG, Oei TPS. The roles of depression and anxiety in the understanding and treatment of obstructive sleep apnea syndrome. Clinical Psychology Review. 2004; 24(8):1031–49.

McGregora BA, Antonib MH. Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain, Behavior, and Immunity. 2009; 23(2):159–66.

Jafari N, Zamani A, Farajzadegan Z, Bahrami F, Emami H, Loghmani A. The effect of spiritual therapy for improving the quality of life of women with breast cancer: a randomized controlled trial. Psychology, Health andMedicine. 2013;18(1):56–69.

Paiva CE, Paiva BS, deCastro RA, Souza CP, de Paiva Maia YC, Ayres JA, et al. A pilot study addressing the impact of religious practice on quality of life of breast cancer patients during chemotherapy. J Relig Health. 2013 Mar; 52(1):184– 93.

Ursaru M, Crumpei I, Crumpei G. Quality of life and religious coping in women with breast cancer. Procedia - Social and Behavioral Sciences. 2014 Feb21; 114:322–6.

Pearce M, Koenig HG. Cognitive behavioural therapy for the treatment of depression in Christian patients with medical illness. Mental Health, Religion and Culture. 2013; 16(7):730–40.

Koenig HG. Religious versus conventional psychotherapy for major depression in patients with chronic medical illness: rationale, methods, and preliminary results. Depression Research and Treatment. 2012;2012.

Pearce MJ, Koenig HG, Robins CJ, Nelson B, Shaw SF, Cohen HJ, et al. Religiously integrated cognitive behavioral therapy: A new method of treatment for major depression in patients with chronic medical illness. Psychotherapy.

; 52(1):56.

Bayanzadeh S, Bolhary J, Dadfar M, Karimi Keisomi I. Effectiveness of cognitive-behavioral religious-cultural therapy in improvement of obsessive-compulsive patients. Razi Journal of Medical Sciences. 2005; 11(44):913–23.

Bellinger D, Berk L, Koenig HG, Daher D, Pearce M, Robins C, et al. Religious involvement, inflammatory markers and stress hormones in major depression and chronic medical illness.Open Journal of Psychiatry. 2014; 4(4):335–52.

Walpole SC, McMillan D, House A, Cottrell D, Mir G. Interventions for treating depression in Muslim patients: a systematic review. J Affect Disord. 2013 Feb 15; 145(1):11–20.

Lim C, Sim K, Renjan V, Sam HF, Quah SL. Adapted cognitivebehavioral therapy for religious individuals with mental disorder: a systematic review. Asian J Psychiatr. 2014 Jun; 9:3–12.

Sharifi V, Asadi SM, Mohammadi MR, Homayoun KHA, Semnani Y, Shabanikia A, et al. Reliability and feasibility of the Persian version of the structured diagnostic interview for DSM-IV (SCID). Advances in Cognitive Science. 2004.

Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version. Health and Quality of Life Outcomes. 2003; 1(1):14.

Koenig H. Cognitive behavioral treatments for depression in patients with chronic illness. Available from: wwwspiritualityand health dukeedu//Full Protocol. 2014.

Sadeghi M, Ladari RB, Haghshenas M. A study of religious attitude and mental health in students of Mazandaran University of Medical Sciences. Journal of Mazandaran University of Medical Sciences. 2010; 20(75):70–5.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993; 85(5):365– 76.

Hamid N, Behslideh K, Bayghi MA, Dehghanizadeh Z.

A study of the effect of religion-based cognitive-behavior therapy on depression in divorced women. Journal of Family Counseling andPsychotherapy. 2011; 1(1):54–64.

Kontodimopoulos N, Ntinoulis K, Niakas D. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. Eur J Cancer Care (Engl). 2011 May; 20(3):354–61.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Quality of Life Research. 2000; 9(2):177–84.

Sadeghi M, Ladari RB, Haghshenas M. A study of religious attitude and mental health in students of Mazandaran university of medical sciences. Journal of Mazandaran University of Medical Sciences. 2010; 20:(75):70–5.

Beck J. Cognitive behavior therapy: basics and beyond. 2nd ed. New York: Guilford Press; 2011.


Refbacks

  • There are currently no refbacks.